Deliverable Volume

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE263.10-2.35 (-0.89 %)
PREV CLOSE ( ) 265.45
OPEN PRICE ( ) 265.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 221516
TODAY'S LOW / HIGH ( )262.00 269.00
52 WK LOW / HIGH ( )217.5 307
NSE263.75-1.5 (-0.57 %)
PREV CLOSE( ) 265.25
OPEN PRICE ( ) 264.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 263.75 (925)
VOLUME 3484465
TODAY'S LOW / HIGH( ) 262.25 269.00
52 WK LOW / HIGH ( )217.5 307.1
Exchange
Period From  
Period To  
Date Total Volume Deliverable Volume Deliverable Volume (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.